arrow
B

Behnam Badie

radiation oncology
H指数:58
被引数:1.2万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

CTIM-07. A PHASE 1 STUDY OF INTRAVENTRICULARLY ADMINISTERED AUTOLOGOUS HER2-TARGETING CHIMERIC ANTIGEN RECEPTOR T CELLS (HER2-CAR T CELLS), WITH AND WITHOUT LYMPHODEPLETION, IN HER2-POSITIVE BREAST CANCER PATIENTS WITH RECURRENT BRAIN AND/OR LEPTOMENINGEAL METASTASES

CTIM-07。一项I期研究,评估经脑室内给药的自体HER2靶向嵌合抗原受体T细胞(HER2-CAR T细胞),在伴或不伴淋巴细胞清除的情况下,用于HER2阳性乳腺癌患者复发脑和/或软脑膜转移的疗效。

2025-11-110
OA
Chlorotoxin-directed CAR T cell therapy for recurrent glioblastoma: Interim clinical experience demonstrating feasibility and safety

氯毒素靶向的CAR T细胞疗法治疗复发性胶质母细胞瘤:中期临床经验表明其可行性和安全性

2025-08-150
PREAI
CONQUERING SPP1+MYELOID-DRIVEN RESISTANCE OF GLIOBLASTOMA TO IL13RA2-TARGETED CAR T CELL THERAPY
2024-11-110
PRE
Locoregional delivery of IL-13Rα2-targeting CAR-T cells in recurrent high-grade glioma: a phase 1 trial (JUNE, 10.1038/s41591-024-02875-1, 2023)
2024-03-210
OAAI
Locoregional delivery of IL-13Rα2-targeting CAR-T cells in recurrent high-grade glioma: a phase 1 trial

Il-13rα2靶向car-t细胞在复发性高级别胶质瘤中的局部区域递送: 1期试验

2024-03-0751
OAAI
PRELIMINARY RESULTS FROM A PHASE I TRIAL TO EVALUATE INTRAVENTRICULAR DELIVERY OF IL13R.2-TARGETING CAR T CELLS AFTER LYMPHODEPLETION IN PEDIATRIC BRAIN TUMORS PATIENTS
2023-06-120
OAAI